<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nonautoimmune <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone diabetic syndromes are increasingly frequent in nonwhite populations </plain></SENT>
<SENT sid="1" pm="."><plain>We have characterized a cohort of patients of sub-Saharan African origin who had <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 111), type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 21), and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 88) and were admitted to a hospital for management of uncontrolled <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We compared epidemiological, clinical, and metabolic features at <z:mp ids='MP_0002055'>diabetes</z:mp> <z:hpo ids='HP_0003674'>onset</z:hpo> and measured insulin secretion (glucagon-stimulated C-<z:chebi fb="7" ids="16670">peptide</z:chebi>) and insulin action (short intravenous insulin tolerance test) during a 10-year follow-up </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001946'>Ketosis</z:hpo>-prone type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> shows a strong male predominance, stronger family history, higher age and BMI, and more severe metabolic decompensation than type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, discontinuation of insulin therapy with development of remission of insulin dependence is achieved in 76% of patients (non-insulin dependent), whereas only 24% of patients remain insulin dependent </plain></SENT>
<SENT sid="5" pm="."><plain>During evolution, <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> exhibit specific <z:hpo ids='HP_0006279'>beta-cell dysfunction</z:hpo> features that distinguish it from type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The clinical course of non-insulin-dependent <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is characterized by ketotic relapses followed or not by a new remission </plain></SENT>
<SENT sid="7" pm="."><plain>Progressive <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> precedes and is a strong risk factor for ketotic relapses (hazard ratio 38) </plain></SENT>
<SENT sid="8" pm="."><plain>The probability for non-insulin-dependent <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> to relapse is 90% within 10 years, of whom approximately 50% will become definitively insulin dependent </plain></SENT>
<SENT sid="9" pm="."><plain>Insulin sensitivity is decreased in equal proportion in both <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but improves significantly in non-insulin-dependent <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, only after correction of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, <z:hpo ids='HP_0001946'>ketosis</z:hpo>-prone type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> can be distinguished from type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and classical type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> by specific features of clinical pathophysiology and also by the natural history of <z:hpo ids='HP_0006279'>beta-cell dysfunction</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> reflecting a propensity to <z:chebi fb="105" ids="17234">glucose</z:chebi> toxicity </plain></SENT>
</text></document>